Artificial Intelligence in the Next Era of Low Vision Care - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Artificial Intelligence in the Next Era of Low Vision Care

This session explored advancements in AI, including generative AI and multimodal capabilities, for patients who have low vision.

  • November 10, 2025

  • 4 min

Share

Clinical Scorecard: Artificial Intelligence in the Next Era of Low Vision Care

At a Glance

CategoryDetail
ConditionLow Vision
Key MechanismsArtificial Intelligence applications enhancing accessibility and independence for individuals with low vision.
Target PopulationIndividuals with low vision or blindness, including those with conditions like macular degeneration, Stargardt disease, and diabetic retinopathy.
Care SettingOptometric and vision rehabilitation settings.

Key Highlights

  • AI is enhancing accessibility for people with low vision, ushering in 'Accessibility 2.0'.
  • Case studies include AI applications like Seeing AI and smart glasses for social engagement.
  • Trust in AI among users is moderate, with an average rating of 2.4 out of 5.
  • Challenges include AI's lack of goal-oriented responses and issues with accuracy.
  • The future of low vision care will be AI-assisted, human-guided, and patient-empowered.

Guideline-Based Recommendations

Diagnosis

  • Utilize AI tools to assist in the assessment of low vision conditions.

Management

  • Incorporate AI applications in rehabilitation programs for low vision patients.

Monitoring & Follow-up

  • Regularly evaluate the effectiveness and user trust in AI tools.

Risks

  • Be aware of AI hallucinations and the need for users to double-check AI outputs.

Patient & Prescribing Data

Individuals with varying degrees of visual impairment.

AI tools can significantly improve independence and quality of life for users.

Clinical Best Practices

  • Educate patients on the safe and ethical use of AI tools.
  • Encourage user feedback to improve AI applications.
  • Promote ongoing research to address limitations and enhance AI reliability.

Related Resources & Content

Original Source(s)

Artificial Intelligence in the Next Era of Low Vision Care

  • November 10, 2025

Related Content

Glaucoma: Applying Glaucoma Strategies to AMD Care

Any glaucoma clinician knows that a robust VF strategy, coupled with structural measures, such as optical coherence tomography (OCT), provides a richer understanding of a patient’s disease than anatomical structure alone. Yet when it comes to age-related macular degeneration (AMD), I would argue that our diagnostic habits are quite different.

Racing Toward Efficient AI Workflows

At the Focus A-Eye Summit, in the session “Lessons from Formula One: Optimizing Clinical Workflow with AI,” experts examined how artificial intelligence can streamline and accelerate ophthalmic clinical workflows.

Efficiency in Prior Authorization Practices

Felecia Jones, COT, BBA, Cynthia Matossian, MD, FACS, and Robert F. Melendez, MD, share how ophthalmology practices can make the PA process simpler and more efficient.